Insmed (INSM) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
EPS Growth %: +78.3%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +78.3%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.74), $0.03 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $34.8 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
